journal clubs | مرکز تحقیقات غدد و متابولیسم

ردیف	تاریخ ارائه	توضیحات
1	1404/7/3	2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
2	1404/2/18	The Porphyrias Disorders of Heme Synthesis
3	1404/2/11	Guideline for the Prevention and Treatment
4	1404/1/28	HYPERTHYROHDISM
5	1404/1/21	درمان با رادیواکتیو رادیواکتیو لودین
6	1404/07/24	ATA-2025
7	1404/07/17	ATA Management Guidelines 2025 for Adult Patients with Differentiated Thyroid
8	1404/07/10	American Thyroid Association Management Guidelines 2025 for Adult Patients with Differentiated Thyroid Cancer
9	1403/12/9	Onset and progression of osteoporosis
10	1403/12/23	Diabetes insipidus
11	1403/12/2	screening or not screening T1D ISPAD 2024 Recommendations
12	1403/12/16	Ramadan and Diabetes
13	1403/11/25	Insulin Resistance and Diabetes Mellitus
14	1403/11/18	Adrenal cortical carcinoma
15	1403/11/11	Management of diabetic foot ulcers
16	1403/10/27	DIABETES AND CANCER
17	1403/10/20	Management of challenging and complicated patients with DM
18	1403/10/13	Dyslipidemia management in pregnant patients: a 2024 update
19	1403/10/06	Adrenal insufficiency:identification and management
20	1403/09/29	Pheochromocytoma and paraganglioma in children
21	1403/09/01	How to manage Cushing’s disease after failed primary pituitary surgery
22	1403/08/24	Surgery of the Adrenal Glands
23	1403/08/24	Surgical Approaches to the Adrenal Gland
24	1403/08/17	Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
25	1403/08/10	Acromegaly
26	1403/08/03	بمپدوییک اسید
27	1403/07/26	postmenopausal osteoporosis
28	1403/07/19	Late night salivary cortisol
29	1403/07/19	Salivary Cortisol test
30	1403/07/12	CKD-MBD
31	1403/07/05	Clinical Indication of FDG PET-CT in DTC
32	1403/04/14	The Genetic Testing in Endocrine Disorders
33	1403/03/31	Cyclic Cushing’s Disease
34	1403/03/20	Primary Aldosteronism Novel Approaches and Future Outlooks
35	1403/03/17	Diabetic Nephropathy
36	1403/03/10	GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
37	1403/03/03	2023 European Thyroid Association Clinical Practice Guidelines for Thyroid nodule management
38	1403/02/27	Bariatric Surgery
39	1403/02/13	Abnormal uterine bleeding in adolescents: Management
40	1403/02/06	Multimodality imaging of primary hyperparthyroidism
41	1403/01/30	Perioperative Evaluation and Management of Patients on Glucocorticoids
42	1403/01/16	Review of ICE 2024
43	1402/12/24	Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities
44	1402/12/17	Medical Nutrition Therapy IN Diabetes
45	1402/12/10	Diabetic Bladder or Diabetic Cystopathy &related complicationc
46	1402/12/03	The Revolution in Cholesterol Management: Putting REPATHA into practice
47	1402/11/26	EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
48	1402/11/12	Glucocorticoidinduced osteoporosis (GIOP)
49	1402/10/28	Thyroid Scintigraphy
50	1402/10/21	MTC
51	1402/10/14	Summary of Revisions: Standards of Medical Care in Diabetes—2024
52	1402/10/07	Summary of Revisions: Standards of Medical Care in Diabetes—2024
53	1402/09/30	OBESITY MANAGEMENT IN ADULTS
54	1402/09/23	پرولاکتینوما
55	1402/09/16	Updates on Thyroid eye disease
56	1402/09/09	Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
57	1402/08/25	Nuclear Medicine In Diabetic Foot
58	1402/08/18	Syndrome of Inappropriate Antidiuresis
59	1402/08/11	Hypothyroidism
60	1402/08/04	Management of Osteoporosis in Postmenopausal Woman
61	1402/07/27	نحوه برخورد با شیرخوار مبتلا به ابهام جنسی
62	1402/07/21	PCOS GUIDLINE 2023
63	1402/07/13	Adrenal Incidentaloma
64	1402/07/06	Acromegaly original
65	1401/08/10	Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
66	1400/04/04	A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
67	1400/03/28	Type 1 Diabetes: Management in Women From Preconception to Postpartum
68	1400/03/21	American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool
69	1400/03/07	Vitamin D Update
70	1400/02/31	Active Surveillance of Adult Low-Risk Papillary Thyroid Carcinoma
71	1400/02/17	Management of Hypertriglyceridemia
72	1400/02/10	Adrenal Incidentaloma
73	1400/02/03	Diagnosis and Treatment of NCCAH due to 21-Hydroxylase Deficiency
74	1400/01/27	New Oral Options for Diabetic Dyslipidemia Managment
75	1400/01/20	Testosterone Deficiency in Men
76	1399/12/22	The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
77	1399/12/15	Role of Nuclear Medicine in Endocrinology
78	1399/12/08	Pituitary Disorders in Pregnancy
79	1399/12/01	IDF DaR Guideline for people with diabetes who want to fast in Ramadan
80	1399/11/24	Thyroid Eye Disease: Managing a Condition with Grave Consequences
81	1399/11/17	Dyslipidemia in Children
82	1399/11/10	Clinical Indication of FDG PET-CT in DTC
83	1399/11/03	Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
84	1399/10/26	Practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours (NET)
85	1399/10/19	Lipid Management in Patients with Endocrine Disorders
86	1399/10/12	Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
87	1399/10/05	ADA 2021 Review
88	1399/09/28	Management of Graves‘ Thyroidal and Extrathyroidal Disease – An Update
89	1399/09/21	Approach to Managing a Postmenopausal Patient
90	1399/09/14	Endocrine Surgery during the Covid-19 pandemic
91	1399/09/07	Turner Syndrome Genome
92	1399/08/30	Glucocorticoid-Induced Osteoporosis
93	1399/08/09	Pituitary Incidentalomas
94	1399/08/02	How to use TBS in combination with BMD in clinical practice
95	1399/07/25	Glucocorticoid Induce Hyperglycemia
96	1399/07/18	Hypoparathyroidism
97	1399/07/11	Normocalcaemic Primary Hyerparathyroidism Normocalcaemic PHP
98	1399/07/04	GLP-1 AGONISTS vs SGLT2-inh ECE 2020
99	1399/03/27	PDE5 Inhibitors in Type 2 Diabetes Mellitus
100	1399/03/20	Dietary Fats and Health Outcome
101	1399/03/13	Medical Treatment with Somatostatin Analogues & Predictive Markers for Post-Surgical Medical Management of Acromegaly
102	1399/03/06	Pituitary-Tumor Endocrinopathies
103	1399/02/30	Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
104	1399/02/23	Osteoporosis in Men
105	1399/02/16	PCOS in Adolescents
106	1399/02/09	Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline
107	1399/02/02	Diabetes & Ramadan Fasting - 2020
108	1399/01/26	COVID-19 and Endocrine System
109	1399/01/20	European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
110	1398/11/29	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
111	1398/11/15	Prolactinoma in Pregnancy and Menopause
112	1398/11/08	Nuclear Medicine & Parathyroid Diseases
113	1398/11/01	Management of Hypopituitarism
114	1398/10/24	Thermal Ablation for Papillary Thyroid Microcarcinomas
115	1398/10/17	ADA 2020 - Standards of Medical Care in diabetes
116	1398/10/10	2019European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
117	1398/10/03	Hypogonadism in Men
118	1398/09/26	Prolactinoma in Pregnancy
119	1398/09/19	Familial hypercholesterolemia in children “Diagnosis and Treatment “
120	1398/09/12	Contemporary Debates in Adult Papillary Thyroid Cancer Management
121	1398/09/05	Management Of Graves Orbitopathy
122	1398/08/28	Management of Difficult Osteoporosis
123	1398/08/21	Medical Management of Cushing’s Syndrome
124	1398/08/14	Prolactinoma
125	1398/07/30	Adrenal Crisis
126	1398/07/23	Drug Effects on the Thyroid
127	1398/07/16	Lipid
128	1398/07/09	Pheochromocytoma and Paraganglioma
129	1398/07/02	AROMATASE INHIBITORS AND BONE - ECE 2019
130	1398/03/28	Endocrine Treatment of Gender - Dysphoric/Transsexual Person
131	1398/03/21	Principles of DXA Scan Interpretation
132	1398/03/07	The Indeterminate Thyroid Nodule
133	1398/02/31	Prevention of Type 1 Diabetes
134	1398/02/24	Management of Medullary Thyroid Cancer
135	1398/02/17	Adrenal Imaging
136	1398/02/10	Osteoprosis Recumendations
137	1398/02/03	The Evaluation of Incidentally Discovered Adrenal Masses
138	1398/01/27	Update on Central Precocious Puberty: From Etiologies to Outcomes
139	1398/01/20	Treatment of Diabetes in Older Adults
140	1397/12/21	Diabetes Technology: Standards of Medical Care in Diabetes 2019
141	1397/12/14	The Management of Primary Aldosteronism Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
142	1397/12/07	Sglt2 Inhibitor
143	1397/11/30	Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism
144	1397/11/23	BMD
145	1397/11/16	Thyroid and Pregnancy
146	1397/11/09	Long-term Safety & Efficacy of GH Treatment
147	1397/11/02	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
148	1397/10/25	The Diagnosis and Management of Nonalcoholic Fatty Liver Disease
149	1397/10/18	Gaps in Guidelines for the Management of Diabetes in Low and Middle-Income Versus High-Income Countries: A Systematic Review
150	1397/10/11	RAI in low risk DTC
151	1397/10/04	Management of Hyperglycemia in Type 2 Diabetes, 2018
152	1397/09/27	Diabetic Neuropathy
153	1397/09/20	OSTEOGENESIS IMPERFECTA
154	1397/09/13	Conventional & New Treatments of Hypoparathyroidism
155	1397/09/06	CONGENITAL ADRENAL HYPERPLASIA
156	1397/08/29	ORAL SEMAGLUTIDE vs PLACEBO
157	1397/08/15	ACROMEGALY
158	1397/08/01	2018European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
159	1397/07/24	Adrenocortical Carcinoma
160	1397/07/17	Gestational Diabetes Underpinning Principles, Surveillance, and Management
161	1397/07/10	2018European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
162	1397/07/03	Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
163	1397/03/29	Charcot Foot
164	1397/03/22	X-linked Hypophosphatemic Rickets and its Treatment with Anti-FGF23
165	1397/03/08	Differentiated Thyroid Cancer Subtypes and Prognosis
166	1397/03/01	Incidence of Bone Metastases in Differentiated Thyroid Cancer
167	1397/02/25	Ramadan Fasting & Health
168	1397/02/18	Testosterone Therapy in Men With Hypogonadism
169	1397/02/11	Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
170	1397/01/28	Acromegaly: An Endocrine Society Clinical Practice Guideline
171	1397/01/21	European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
172	1397/01/14	Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
173	1396/12/22	Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Managment Algorithm-2018 Executive Summary
174	1396/12/15	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
175	1396/12/08	Some Points & Recommendations for Diagnosis Growth Hormone Deficiency in Children and Adolescents
176	1396/11/24	Definition of Pheochromocytomaand Paraganglioma (PPGL)
177	1396/11/17	Magnetic Resonance Imaging of Pituitary Tumors
178	1396/11/10	Diagnosis and Treatment PCOS
179	1396/11/03	Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
180	1396/10/26	KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, revention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
181	1396/10/19	Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents
182	1396/10/12	Clinically Nonfunctioning Pituitary Adenomas
183	1396/10/05	Standards of Medical Care in Diabetes - 2018
184	1396/09/28	AACE FOR MANAGEMENT OF DYSLIPIDEMIA
185	1396/09/14	Pituitary Apoplexy
186	1396/09/07	Non-Classic Congenital Adrenal Hyperplasia
187	1396/08/30	Nuclear Medicine in Neuroendocrine Tumors
188	1396/08/23	Type 2 Diabetes and Osteoporosis
189	1396/08/16	The Management of Primary Aldosteronism
190	1396/08/09	Prolactinoma
191	1396/08/02	PERIPHERAL PRECOCITY
192	1396/07/25	The follicular-variant papillary thyroid cancer (FVPTC)
193	1396/07/18	Gestational Diabetes Mellitus
194	1396/07/11	Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer - When to Use Systemic Therapy
195	1396/07/04	Management of Graves Orbitopathy ECE2017
196	1396/03/30	Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
197	1396/03/23	Pathogenesis and management of hypoglycemia
198	1396/03/16	Diabetes and Ramadan
199	1396/03/09	Combination Therapy in DM2
200	1396/03/02	Gastrointestinal Manifestations of Diabetes
201	1396/02/26	Ovarian Hyperthecosis
202	1396/02/19	Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
203	1396/02/12	An update on sodium-glucose co transporter-2 inhibitors for the treatment of diabetes mellitus
204	1396/01/15	Physiological and molecular responses to bariatric
205	1395/12/17	Physical activity and exercise in children with diabetes mellitus type 1
206	1395/12/10	Pseudohypoparathyroidism, Albright’s Hereditary Osteodystrophy-Disorders Caused by Inactivating GNAS Mutations
207	1395/11/26	Management of Osteoporosis
208	1395/11/19	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
209	1395/11/12	2017Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum
210	1395/11/07	Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly
211		Postoperative Management Following Pituitary Surgery
212		Diabetes and Ramadan: Practical Guidelines
213		The Increasing Incidence of Thyroid Cancer
214		EASD (2016)
215		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules
216		Achieving and Maintaining Weight Loss in Obesity: Clinical Evidence for Novel Approaches
217		European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for phaeochromocytomaor a paraganglioma
218		Approach to diabetes mellitus in children and Adolescents
219		Postmenopausal Osteoporosis
220		Diagnostic tests of cushing syndrome
221		RED CELL TRANSFUSION
222		DPP-4 inhibitors
223		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
224		Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
225		Limitation of current approaches for the treatment of acromegaly
226		COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM
227		Primary ovarian insufficiency (POI)
228		Comprehensive Type 2 Diabetes Managment Algorithm (part 2)
229		Primary Male Hypogonadism and Testosterone Therapy
230		Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
231		Timing of multiple endocrine neoplasia thyroidectomy and extent of central nacklymphadenectomy
232		Hyperglycemia Management In Patients With Post Transplantation Diabetes
233		2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
234		Premature Ovarian Failure Clinical Presentation and Treatment
235		Clinical Practice Guidlines for the Diagnosis and Treatment of Postmenopausal Osteoprosis (2016)
236		Premature adrenarche
237		Diabetic Sensory and Motor Neuropathy
238		Update on subclinical thyroid dysfunction
239		Thyroid lymphoma
240		Glinids & Metformin
241		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis
242		Pharmacotherapy for obesity and type 2 diabetes
243		Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 <span data-scayt_word="mL" data-scaytid="146">mL/min) - Dr.Karimifard
244		Postsurgical hypoparathyroidism definitions and management
245		Standards of Medical Care in Diabetes — 2016
246		Thiazolidinediones Alpha and Glucosidase Inhibitors
247		Effect of Somatostatin Analogs on the Cardiovascular System in Acromegaly: A Metaanalysis
248		2016American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis part 2
249		Alcohol Ablation It’s indication, Efficacy, and Safety in Thyroid Disease
250		Central precocious puberty